Tweet

Jocalyn Clark

25 Aug, 8 tweets, 5 min read

@TheLancet

📣Great NEW content featured on @TheLancet homepage - "Advancing women in science & health"

1/ Black #womeninmedicine - rising above invisibility by @onyi_eke @OnyekaOtugo @DrJessIsomMDMPH

thelancet.com/journals/lance…

@HelenaTeede

2/ Advancing women in healthcare leadership: systematic review of multi-sector evidence on organisational interventions by @HelenaTeede & colleagues

thelancet.com/journals/eclin…

https://twitter.com/jocalynclark/status/1421031782896570376

Scientific medical conferences can be easily modified to improve female inclusion: a prospective study 👇🏼

https://twitter.com/jocalynclark/status/1421031782896570376

Sensational editorial @LancetEndo on gender gaps in publishing & how to act. "When everyone is included, everyone wins." 👏🏼 #DiversityandInclusion

thelancet.com/journals/landi…

@arghavan_salles

Institutional imperatives for the advancement of #WomenInMedicine & #WomenInSTEM through the COVID-19 pandemic by @arghavan_salles @reshmajagsi #LancetWomen

thelancet.com/journals/lance…

thank you Dr Isom for this powerful piece! So happy we're upping it again.

@TheLancet

Displayed prominently on homepage lancet.com / 🙏 to web colleagues @TheLancet for the idea of a new collection & putting it together.

@TheLancetEndo

Oops @TheLancetEndo

• • •

Missing some Tweet in this thread? You can try to force a refresh

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @jocalynclark

Jocalyn Clark

@jocalynclark

24 Jul 20

@TheLancet

6 months to the day that I wrote our lead @TheLancet editorial on a mysterious new pneumonia-like outbreak drafting it in 3 hours instead of the usual 3 days. Colleagues gave input in 1 h instead of 24 h. 6 months for the world to change forever. #writing
thelancet.com/journals/lance…

Writing a leader under those conditions is risky: what was the outbreak & would it spread? Are we making something of nothing? Should we go soft or hard on China’s response & transparency? What about this ‘lockdown’ of Wuhan, an intervention we thought of as draconian (ha ha).

Our EIC edited the leader; we waited overnight for WHO to decide about the PHEIC. New cases from around the world were reported (we couldn't keep up). We had the first 2 research reports from China describing the novel coronavirus.....We were under pressure to go live ASAP.

Read 19 tweets

Jocalyn Clark

@jocalynclark

29 Apr 20

@TheLancet

What distinguishes this new #remdesivir trial in @TheLancet is that it was:

1. Peer-reviewed & professionally edited

2. Done by scientists w/o financial or other links to the drug's manufacturer, Gilead

3. Was "well conducted w/ high protocol adherence & no loss to followup"..

https://twitter.com/TheLancet/status/1255513005506215936

4. Accompanied by a commentary written by a leading statistical expert who calls for

5. "data sharing... allowing rapid curation of relevant datasets for individual patient data meta-analyses..."

and our "best way to obtain robust insights" on treatments for #COVID19 ...